The effectiveness of PRP is likely superior to that of HA, with a longer effective duration. Discrepancy in the degenerative severity modified the treatment response, leading the participants with a lower degree of knee degenerative lesions to benefit more from PRP injections. We suggest

that future studies target the population with mild to moderate knee OA based on Selleck BTK inhibitor the consideration of clinical utility. a. StataCorp LP, 4905 Lakeway Dr, College Station, TX 77845-4512. “
“Osteoarthritis (OA) is the most common form of arthritis and is identified as one of the leading causes of pain and disability worldwide.1 and 2 By the year 2020, the prevalence of OA is expected to double.3 The risk factors associated with

OA include age, sex, genetics, occupation, past injuries, and obesity.4 Hip and knee pain associated with OA often leads to inactivity and loss of mobility, resulting in deconditioning, weight gain, loss of independence, and decreased quality of life.5 There are substantial personal and societal costs associated selleck compound with OA.1 Personal costs may include the inability to participate in work, sport, hobbies, or caring for others because of pain. Societal costs may include visits to the doctor, medication costs, and assistance equipment. Joint replacement is an effective intervention to alleviate pain and improve quality of life for those with advanced OA. However, despite a growing number of joint Decitabine order replacements undertaken each year, many people are still placed on a waiting list often for a considerable time.6 and 7 To reduce the burden of OA, safe and effective health services, involving a range

of nonsurgical treatments options, are required. These services must be effective with respect to intervention and cost as well as meet the affected person’s needs. Evidence-based clinical guidelines are developed to assist the practitioner, patient, and/or policymaker to make informed clinical decisions.8 Guidelines are valuable resources that play an integral role in improving treatment and management of various health conditions. They can be used by health practitioners and people suffering with OA seeking information to determine how their disease can best be managed. A preliminary search of the literature identified many international guidelines developed for the management of OA. The preliminary search identified that the guidelines included evidence and recommendations for a number of interventions including pharmacological, nonpharmacological, surgical, and injection therapies, physical management, and lifestyle changes for the management of OA. However, because of adverse effects, patients and health care providers may pursue physical management options rather than surgery, pharmacology, or injection-based therapy. A number of guidelines highly recommend exercise as an intervention for OA.